Pharmacy Daily | FDA ticks MGN test

Other recent headlines

• 

  Legal action for Montu

  Friday | Apr 19 2024

  MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.

  
• 

  Call to unblock wait times

  Friday | Apr 19 2024

  AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).

  
• 

  New pelvic pain study

  Friday | Apr 19 2024

  THE University of South Australia has released a new study to help healthcare workers better support women with persistent pelvic pain, including symptoms that are suggestive of gynaecological, lower urinary tract, bowel, sexual, and pelvic floor dysfunction.